CAMK2B and Alzheimer disease: Additional CEs in CAMK2B, PFKP, SYT7, and ARHGAP32 also showed significant disease-related differences (ANOVA p < 0.05 for all comparisons), with higher levels of CE inclusion in AD+LATE cases.